2025
SJR Q2
JCR Q3 · 2
92 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Tissue Engineering and Regenerative Medicine
- Yayıncı
- John Wiley and Sons Inc
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1932625419327005
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,62
- Quartile Q2
- H-Index 101
- Atıf/yayın 1,76
- Doküman (3y) 147
- Atıf (3y) 449
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 3,2
- JCI 0,48
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
Alanlar
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,62 | 2 | 3,2 | 0,48 | Q3 | 101 |
| 2024 | Q2 | Q3 | 0,665 | 2,6 | 3,5 | 0,54 | Q3 | 95 |
| 2023 | Q2 | Q2 | 0,62 | 3,1 | 3,9 | 0,59 | Q3 | 95 |
| 2022 | Q2 | Q2 | 0,654 | 3,3 | 3,7 | 0,65 | Q2 | 95 |
| 2021 | Q2 | Q2 | 0,734 | 4,3 | 4,1 | 0,74 | Q2 | 95 |
| 2020 | Q2 | Q2 | 0,835 | 4 | 4 | 0,84 | Q2 | 95 |
| 2019 | Q2 | Q2 | 0,84 | 3,1 | 3,2 | 0,95 | Q2 | 95 |
| 2018 | — | Q2 | — | 3,3 | 3,4 | 1,08 | Q1 | — |
| 2017 | Q2 | Q1 | 0,88 | 4,1 | 3,8 | 1,05 | Q1 | 95 |
| 2016 | Q2 | Q1 | 0,858 | 4 | 3,9 | — | — | 95 |
| 2015 | Q1 | Q1 | 0,924 | 4,7 | 4,1 | — | — | 95 |
| 2014 | Q1 | Q1 | 1,057 | 5,2 | 4,3 | — | — | 95 |
| 2013 | Q1 | Q1 | 1,09 | 4,4 | 4 | — | — | 95 |
| 2012 | Q1 | Q1 | 1,138 | 2,8 | 3,7 | — | — | 95 |
| 2011 | Q1 | Q1 | 1,453 | 3,3 | 4,1 | — | — | 95 |
| 2010 | Q1 | Q1 | 1,443 | 3,5 | 4,1 | — | — | 95 |
| 2009 | — | Q1 | — | 3,9 | 3,9 | — | — | — |
| 2008 | — | Q3 | — | 1,6 | 1,6 | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q3 | 137/180 |
| 2025 | CELL BIOLOGY | SCIE | Q4 | Q3 | 172/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 27/32 |
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 94/130 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | Q3 | 101/177 |
| 2024 | CELL BIOLOGY | SCIE | Q3 | Q3 | 139/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 22/32 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 72/124 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q3 | 82/174 |
| 2023 | CELL BIOLOGY | SCIE | Q3 | Q3 | 127/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 21/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 59/123 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 76/158 |
| 2022 | CELL BIOLOGY | SCIE | Q3 | Q3 | 123/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 19/29 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 55/96 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 58/159 |
| 2021 | CELL BIOLOGY | SCIE | Q3 | Q2 | 109/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 18/29 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 42/98 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 59/159 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q2 | 119/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 17/29 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 29/89 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 63/156 |
| 2019 | CELL BIOLOGY | SCIE | Q3 | Q2 | 119/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 20/29 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 33/87 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q1 | 52/162 |
| 2018 | CELL BIOLOGY | SCIE | Q3 | Q2 | 106/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 16/26 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q1 | 23/80 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 27/161 |
| 2017 | CELL BIOLOGY | SCIE | Q2 | Q2 | 69/190 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 7/24 |
| 2017 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | Q1 | 10/78 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 29/160 |
| 2016 | CELL BIOLOGY | SCIE | Q2 | — | 70/190 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 7/21 |
| 2016 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 9/77 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 19/161 |
| 2015 | CELL BIOLOGY | SCIE | Q2 | — | 47/187 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 4/21 |
| 2015 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 5/76 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 17/163 |
| 2014 | CELL BIOLOGY | SCIE | Q1 | — | 45/184 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 5/21 |
| 2014 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 5/76 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 21/165 |
| 2013 | CELL BIOLOGY | SCIE | Q2 | — | 64/185 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 4/18 |
| 2013 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 5/76 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 51/160 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 104/185 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 12/17 |
| 2012 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 14/79 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 43/158 |
| 2011 | CELL BIOLOGY | SCIE | Q2 | — | 90/181 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 9/12 |
| 2011 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 10/72 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 36/160 |
| 2010 | CELL BIOLOGY | SCIE | Q2 | — | 85/178 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 6/13 |
| 2010 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 6/70 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 27/152 |
| 2009 | CELL BIOLOGY | SCIE | Q2 | — | 66/162 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 5/12 |
| 2009 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 4/59 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 88/144 |
| 2008 | CELL BIOLOGY | SCIE | Q4 | — | 128/157 |
| 2008 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 32/52 |